Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

ClinicalTrials.gov ID: NCT00077636

Public ClinicalTrials.gov record NCT00077636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 1:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label Study of the Effect of PEGASYS and Ribavirin Combination Therapy on Sustained Virologic Response in Interferon-naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of different durations of treatment with PEGASYS combined with ribavirin in patients with CHC genotype 2 or 3 infection who have never previously received interferon (IFN) therapy. The anticipated time on study treatment is 3-12 months and the target sample size is 500+ individuals.

Study identification

NCT ID
NCT00077636
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,469 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2003 (Type not available)
Primary completion
Mar 2006 (Actual)
Completion
Mar 2006 (Actual)
Last update posted
Feb 23, 2016

2003 – 2006

United States locations

U.S. sites
88
U.S. states
35
U.S. cities
78
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294 —
Not listed Mobile Alabama 36693 —
Not listed Anchorage Alaska 99508 —
Not listed Phoenix Arizona 85006 —
Not listed Scottsdale Arizona 85259 —
Not listed Little Rock Arkansas 72205 —
Not listed La Jolla California 92037-1030 —
Not listed Long Beach California 90822 —
Not listed Los Angeles California 90048 —
Not listed Palo Alto California 94304-1509 —
Not listed Sacramento California 95825-2115 —
Not listed San Diego California 92105 —
Not listed San Diego California 92123 —
Not listed San Diego California 92154 —
Not listed San Francisco California 94115 —
Not listed San Francisco California 94121 —
Not listed San Luis Obispo California 93401 —
Not listed Littleton Colorado 80120 —
Not listed Farmington Connecticut 06030 —
Not listed Bradenton Florida 34209 —
Not listed Gainesville Florida 32610-0214 —
Not listed Jacksonville Florida 32207 —
Not listed Jacksonville Florida 32209 —
Not listed Miami Florida 33136 —
Not listed Orlando Florida 32803 —
Not listed Pensacola Florida 32514 —
Not listed Tampa Florida 33612 —
Not listed Wellington Florida 33414 —
Not listed Atlanta Georgia 30309 —
Not listed Austell Georgia 30106 —
Not listed Honolulu Hawaii 96817 —
Not listed Boise Idaho 83702 —
Not listed Moline Illinois 61265 —
Not listed Indianapolis Indiana 46202 —
Not listed Iowa City Iowa 52242 —
Not listed Iowa City Iowa 52246 —
Not listed Baton Rouge Louisiana 70805 —
Not listed New Orleans Louisiana 70112 —
Not listed Baltimore Maryland 21201 —
Not listed Baltimore Maryland 21205 —
Not listed Boston Massachusetts 02118 —
Not listed Boston Massachusetts 02720 —
Not listed Burlington Massachusetts 01805 —
Not listed Worcester Massachusetts 01655 —
Not listed Ann Arbor Michigan 48109-0362 —
Not listed Detroit Michigan 48202-2689 —
Not listed Minneapolis Minnesota 55417 —
Not listed Plymouth Minnesota 55446 —
Not listed St Louis Missouri 63104 —
Not listed Albuquerque New Mexico 87108 —
Not listed Bayside New York 11358 —
Not listed Binghamton New York 13903 —
Not listed Manhasset New York 11030 —
Not listed New York New York 10003 —
Not listed New York New York 10021 —
Not listed The Bronx New York 10468 —
Not listed Williamsville New York 14221 —
Not listed Chapel Hill North Carolina 27599-7584 —
Not listed Durham North Carolina 27710 —
Not listed Fayetteville North Carolina 28304 —
Not listed Statesville North Carolina 28677 —
Not listed Cincinnati Ohio 45267-0595 —
Not listed Cleveland Ohio 44106 —
Not listed Portland Oregon 97220 —
Not listed Hershey Pennsylvania 17033 —
Not listed Lancaster Pennsylvania 17604-3200 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Cranston Rhode Island 02920 —
Not listed Providence Rhode Island 02905 —
Not listed Germantown Tennessee 38138 —
Not listed Dallas Texas 75203 —
Not listed Dallas Texas 75235-9151 —
Not listed Fort Sam Houston Texas 78234-3879 —
Not listed Houston Texas 77030 —
Not listed Salt Lake City Utah 84121 —
Not listed White River Junction Vermont 05009-0001 —
Not listed Charlottesville Virginia 22902 —
Not listed Chesapeake Virginia 23320-1706 —
Not listed Falls Church Virginia 22042 —
Not listed Richmond Virginia 23249 —
Not listed Bellevue Washington 98004 —
Not listed Kirkland Washington 98034 —
Not listed Puyallup Washington 98372 —
Not listed Seattle Washington 98133 —
Not listed Seattle Washington 98195 —
Not listed Spokane Washington 99220-3649 —
Not listed Madison Wisconsin 53792 —
Not listed Cheyenne Wyoming 82001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00077636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2016 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00077636 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →